Literature DB >> 10553051

Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins.

N Feuerstein1, F Chen, M Madaio, M Maldonado, R A Eisenberg.   

Abstract

Abrogation of peripheral tolerance in transgenic mice that express a uniform B-cell receptor may create a powerful tool to examine the molecular mechanisms that underlie the autoimmune response in B cells. Here we report that processes that induce a systemic lupus erythematosus-like syndrome in normal mice, namely chronic graft vs host reaction, trigger systemic autoimmunity in a well-established transgenic mice model of B cell receptor peripheral tolerance. The induction of graft vs host reaction in mice that carry both a rearranged B cell Ag receptors specific for hen egg lysozyme and expressing chronically circulating hen egg lysozyme Ag resulted in induction of high and sustained levels of circulating anti-hen egg lysozyme autoantibodies and glomerulonephritis with proteinuria. This was associated with marked changes in expression of cell-surface proteins, such as CD23 and complement receptor 2. B cells from the graft vs host-induced mice could proliferate in vitro in response to self-Ag, and upon stimulation with anti-IgD demonstrated rapid phosphotyrosine phosphorylation of specific proteins, which could not be induced in the anergic double transgenic B cells. Conversely, loss of tolerance was not associated with a higher induction in the level of Syk kinase phosphorylation following stimulation with anti-IgD. Taken collectively, these data establish that 1) processes that induce a systemic lupus erythematosus-like syndrome in normal mice can abrogate peripheral tolerance in transgenic mice expressing self-tolerized B cells, and that 2) loss of tolerance in this model is associated with marked changes in surface expression of B cell coreceptors as well as with selective changes in IgD-induced signaling by discrete tyrosine-phosphoproteins, but not Syk kinase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.

Authors:  Dong Liu; Jian-Ying Zhu; Zhong-Xiang Niu
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

3.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

Review 4.  Secondary receptor editing in the generation of autoimmunity.

Authors:  Robert A Eisenberg
Journal:  Autoimmun Rev       Date:  2012-02-14       Impact factor: 9.754

Review 5.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

Review 6.  Mechanisms of autoimmunity.

Authors:  Robert Eisenberg
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Tumor necrosis factor receptor-associated factor 1 influences KRN/I-Ag7 mouse arthritis autoantibody production.

Authors:  Tao Cheng; Yongwon Choi; Terri H Finkel; Patricia Y Tsao; Mei Qing Ji; Robert A Eisenberg
Journal:  J Clin Immunol       Date:  2013-01-26       Impact factor: 8.317

Review 8.  B-cell anergy: from transgenic models to naturally occurring anergic B cells?

Authors:  John C Cambier; Stephen B Gauld; Kevin T Merrell; Barbara J Vilen
Journal:  Nat Rev Immunol       Date:  2007-07-20       Impact factor: 53.106

9.  Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region.

Authors:  Christopher M Snyder; Katja Aviszus; Ryan A Heiser; Daniel R Tonkin; Amanda M Guth; Lawrence J Wysocki
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

Review 10.  B cell abnormalities in systemic lupus erythematosus.

Authors:  Amrie C Grammer; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2003-12-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.